Skip to content

Laser for nerve injuries

Transcutaneous laser for treatment of amputation neuromas

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN17392017
Enrollment
10
Registered
2022-08-30
Start date
2022-10-20
Completion date
Unknown
Last updated
2022-09-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Amputation neuromata Surgery Neuroma of amputation stump

Interventions

As part of routine clinical diagnostics, the following is performed, a neuroma is identified on ultrasound
the nerve “feeding” the neuroma is identified on ultrasound. Subsequently, a diagnostic injection of local anaesthetic is made. Temporary relief of pain is a positive diagnostic test for an amputation

Sponsors

Swansea Bay University Health Board
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Adult patients (aged >18 years) 2. Capable of giving informed consent 3. Any Fitzpatrick skin type 4. Have undergone amputation (any method) subsequently complicated by the development of reduction (stump) neuroma 5. The patient is not eligible, or declines, further conventional treatment

Exclusion criteria

Exclusion criteria: 1. Photosensitising or photo-bio-modulating medications 2. Patients on psoralens 3. Patients suffering from any condition aggravated by near infra-red wavelengths 4. Patients suffering from porphyria 5. Patients on anticoagulants 6. Any condition where laser is contraindicated 7. Patients with overlying skin breaches or infection 8. Patients on anticoagulants 9. Patients with concomitant neurological conditions 10. Patients with a known history of altered sensation (e.g. Charcot’s illness) 11. Patients objecting to receiving treatment with laser 12. Patients who are pregnant 13. Patients who object to their GP being notified. 14. Patients with no targetable nerve/s identified on ultrasound 15. Patients where diagnostic injection of local anaesthetic fails to confirm a targetable nerve

Design outcomes

Primary

MeasureTime frame
Pain scores recorded on a 1-10 validated scale pre- and post-treatment

Secondary

MeasureTime frame
1. Mobility measured using the Disabilities of Arm, Shoulder and Hand (DASH) score for the upper limb and the Basic Amputee Mobility Score (BAMS) for the lower limb pre- and post-treatment 2. Neuroma size measured in mm through transcutaneous ultrasound pre- and post-treatment

Countries

United Kingdom, Wales

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026